top of page

RA Abstracts

Impact of Adverse Events Associated With Medications in the Treatment and Prevention of Rheumatoid Arthritis

Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis

Immunomodulatory nanodiamond aggregate-based platform for the treatment of rheumatoid arthritis

The Natural History of Rheumatoid Arthritis

Nomenclature for the Phases of the Development of Rheumatoid Arthritis

Abstract Library

Community Forum

bottom of page